GlaxoSmithKline (JOBS) May Shed 6% of R&D Staff to Save Costs

LONDON, Sept 30 (Reuters) - GlaxoSmithKline said on Tuesday it was planning to cut up to 850 research and development jobs in Britain and the United States, in a bid to improve productivity.

MORE ON THIS TOPIC